Skip to content

Clinical trials

Phase 2 Carcinoma, Renal Cell trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 2 Country / region: Australia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20091
20122
20151
20161
20175
20181
20191
20202
20212
20221
20233
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting4
Unknown status4
Terminated2
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
Australian and New Zealand Urogenital and Prostate Cancer Trials Group3
Novartis Pharmaceuticals3
GlaxoSmithKline2
Hoffmann-La Roche2
Peter MacCallum Cancer Centre, Australia2
Bristol-Myers Squibb1
Calithera Biosciences, Inc1
Children's Oncology Group1
Eastern Cooperative Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell27
Kidney Neoplasms6
Melanoma5
Carcinoma, Non-Small-Cell Lung4
Brain Neoplasms2
Head and Neck Neoplasms2
Ovarian Neoplasms2
Pancreatic Neoplasms2
Sarcoma2
Breast Neoplasms1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.